SWTX(Delisted)
SpringWorks (SWTX) Stock Statistics, Valuation & Financial Metrics
Total Valuation
SpringWorks market cap is -- and enterprise value is --.
Share Statistics
SpringWorks has 75.35M shares outstanding, with a free float of 72.94M.
Valuation Ratios
SpringWorks's PE ratio is --, PB ratio is --, and PS ratio is --, showing whether the stock looks expensive or cheap.
Solvency
SpringWorks debt-to-equity ratio is 0 and debt-to-assets ratio is 0.17.
Liquidity
SpringWorks's current ratio is 4.33, quick ratio is 4.18, and cash ratio is 3.5, showing its short-term liquidity position.
Return on Capital
SpringWorks's ROE is -51.57%, ROA is -43.70%, and ROIC is -53.76%, showing its return on capital profile.
Profitability
SpringWorks gross margin is 93.23%, operating margin is -120.52%, and net margin is -115.60%.
Cost Structure
SpringWorks spends 89.45% of revenue on R&D and 124.30% on SG&A.
Operating Efficiency
SpringWorks's asset turnover is 0.38, inventory turnover is 1.69, and receivables turnover is 7.86, indicating its operating efficiency.
Income Statement
SpringWorks's revenue is 219.67M, gross profit is 204.79M, net income is -253.93M, and EBITDA is --.
Balance Sheet
SpringWorks's total debt is 0, net debt is 0, total equity is 417.39M, and cash is 287.87M.
Cash Flow Statement
SpringWorks's operating cash flow is -165.43M, free cash flow is -185.58M, and CapEx is -20.15M.
Dividends & Yields
SpringWorks dividend yield is --, with a payout ratio of -- and dividend per share of --.
Analyst Rating
SpringWorks's latest analyst rating is Unrate, with an analyst target price of --.
Company Info
A biopharmaceutical company focused on developing targeted oncology therapies
Per Share Metrics
SpringWorks's EPS is -3.41, book value per share is 5.57, and free cash flow per share is --.
